Table 3 |
||||
|
Results of the physical health dimension of the SF-36v2 in 16 evaluable subjects |
||||
| Study groups and time points |
SF-36v2 scores, mean (SD) |
|||
|
|
||||
| Physical functioning |
Role-physical |
Bodily pain |
General health |
|
|
|
||||
| Hyal-Joint® (n = 8) |
||||
| Baseline |
31.8 (9.5) |
36.1 (9.3) |
33.7 (5.5) |
48.5 (9.9) |
| Week 4 |
34.9 (7.1) |
42.2 (7.2) |
39.5 (4.5) |
46.0 (10.8) |
| Week 8 |
34.2 (11.0) |
42.8 (6.8) |
44.9 (10.1) |
51.3 (9.2) |
| Change baseline vs week 4 |
3.1 (5.2) |
6.1 (3.9) |
5.8 (4.7) |
-2.5 (8.8) |
| P value |
0.137 |
0.003 |
0.011 |
0.444 |
| Change baseline vs week 8 |
2.4 (5.2) |
6.8 (7.8) |
11.1 (9.6) |
2.8 (9.7) |
| P value |
0.239 |
0.045 |
0.013 |
0.439 |
| Placebo (n = 8) |
||||
| Baseline |
25.5 (7.5) |
41.6 (8.3) |
36.4 (4.8) |
46.5 (10.4) |
| Week 4 |
30.5 (9.7) |
41.9 (11.6) |
39.5 (5.6) |
44.4 (8.4) |
| Week 8 |
33.1 (9.0) |
44.6 (9.3) |
38.6 (5.4) |
48.4 (7.9) |
| Change baseline vs week 4 |
5.0 (5.1) |
0.3 (5.6) |
3.2 (3.7) |
-2.1 (4.9) |
| P value |
0.028 |
0.884 |
0.045 |
0.267 |
| Change baseline vs week 8 |
7.6 (5.2) |
3.1 (5.0) |
2.2 (4.4) |
1.9 (5.5) |
| P value |
0.004 |
0.129 |
0.199 |
0.360 |
|
|
||||
|
Kalman et al. Nutrition Journal 2008 7:3 doi:10.1186/1475-2891-7-3 |
||||
